Odronextamab Uses, Dosage, Side Effects and more
Odronextamab is under investigation in clinical trial NCT03888105 (Assess the Anti-tumor Activity and Safety of Odronextamab in Patients With Relapsed or Refractory B-cell Non-hodgkin Lymphoma).
| Attribute | Details |
|---|---|
| Trade Name | Odronextamab |
| Generic | Odronextamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
